The Claim
In human retinal pigment epithelial (ARPE-19) cells exposed to UV radiation, a lutein-zeaxanthin-curcuminoid formulation (iXAN™) at 500 µg/mL significantly reduces intracellular accumulation of the phototoxic compound A2E by approximately 24% compared to UV-exposed controls, while maintaining cell viability above 100%.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In human retinal cells exposed to UV light, a specific supplement formulation at 500 µg/mL reduces the buildup of a toxic compound called A2E by 24% compared to cells not treated with the supplement, and does not reduce cell survival.
See the scientific wording
In human retinal pigment epithelial (ARPE-19) cells exposed to UV radiation, a lutein-zeaxanthin-curcuminoid formulation (iXAN™) at 500 µg/mL significantly reduces intracellular accumulation of the phototoxic compound A2E by approximately 24% compared to UV-exposed controls, while maintaining cell viability above 100%.
Lutein, zeaxanthin, and curcuminoids enter retinal cells and stop harmful molecules from forming by soaking up dangerous free radicals. This prevents the buildup of a toxic compound called A2E, which damages the cell's waste disposal system. With less damage, the cell stays alive and functions normally.
What the research says
1 studyIn lab-grown eye cells damaged by UV light, this supplement reduced a harmful toxin by about a quarter and kept nearly all the cells alive — even better than the claim said. So yes, it works as described.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.